GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medlive Technology Co Ltd (HKSE:02192) » Definitions » Price-to-Free-Cash-Flow

Medlive Technology Co (HKSE:02192) Price-to-Free-Cash-Flow : 81.35 (As of May. 12, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Medlive Technology Co Price-to-Free-Cash-Flow?

As of today (2024-05-12), Medlive Technology Co's share price is HK$8.46. Medlive Technology Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.10. Hence, Medlive Technology Co's Price-to-Free-Cash-Flow Ratio for today is 81.35.

The historical rank and industry rank for Medlive Technology Co's Price-to-Free-Cash-Flow or its related term are showing as below:

HKSE:02192' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 55.66   Med: 102.75   Max: 332.32
Current: 82.38

During the past 6 years, Medlive Technology Co's highest Price-to-Free-Cash-Flow Ratio was 332.32. The lowest was 55.66. And the median was 102.75.

HKSE:02192's Price-to-Free-Cash-Flow is ranked worse than
84.21% of 57 companies
in the Medical Distribution industry
Industry Median: 21.27 vs HKSE:02192: 82.38

Medlive Technology Co's Free Cash Flow per Share for the six months ended in Dec. 2023 was HK$0.07. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was HK$0.10.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Medlive Technology Co was -2.80% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -18.50% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 25.50% per year.

During the past 6 years, Medlive Technology Co's highest 3-Year average Free Cash Flow per Share Growth Rate was 38.30% per year. The lowest was -18.50% per year. And the median was 36.20% per year.


Medlive Technology Co Price-to-Free-Cash-Flow Historical Data

The historical data trend for Medlive Technology Co's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlive Technology Co Price-to-Free-Cash-Flow Chart

Medlive Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - 332.32 80.47 82.33

Medlive Technology Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only 332.32 - 80.47 - 82.33

Competitive Comparison of Medlive Technology Co's Price-to-Free-Cash-Flow

For the Medical Distribution subindustry, Medlive Technology Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medlive Technology Co's Price-to-Free-Cash-Flow Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medlive Technology Co's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Medlive Technology Co's Price-to-Free-Cash-Flow falls into.



Medlive Technology Co Price-to-Free-Cash-Flow Calculation

Medlive Technology Co's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=8.46/0.104
=81.35

Medlive Technology Co's Share Price of today is HK$8.46.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medlive Technology Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.10.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Medlive Technology Co  (HKSE:02192) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Medlive Technology Co Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Medlive Technology Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Medlive Technology Co (HKSE:02192) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Baijialou Chaoyang North Road, E1 Red Manor International Bonded Innovation Park, Chaoyang District, Beijing, CHN
Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.

Medlive Technology Co (HKSE:02192) Headlines

No Headlines